Why CME Group Inc. (CME) stock moved
CME Group Inc. (CME) shares climbed 6.2% to $251.99 as of July 22, 2026, a significant gain from the prior close of $237.38. BestStocks flagged the session as a major change for CME. Below, we break down what changed for CME, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CME climbed 6.2% to $251.99
CME Group beat Q2 earnings expectations on July 22, posting EPS of $2.99 versus consensus of $2.91 and revenue of $1.71 billion, driven by the second-highest trading volume in company history (PRNewswire, Zacks). The stock rallied 6.84% to $253.60, reflecting investor confidence in the resilience of its core exchange and clearing businesses. Investor call commentary and forward guidance for Q3 2026, plus any updates on trading volumes and client activity trends in the coming weeks.
What it means for CME Group Inc. investors
For CME Group Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Strong 6.2% price move on light volume; CME Group beat Q2 earnings expectations on July 22, posting EPS of $2.99 versus consensus of $2.91 and revenue of $1.71 billion, driven by the second-highest trading volume in company history (PRNewswire, Zacks). Weighing against that: CME Group Inc. (CME) moved -3.15% from $245.11 to $237.38 on 2026-07-21; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $303.33, implying +20.4% upside from $251.99. Over the past 90 days analysts logged 2 upgrades and 1 downgrade. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 98 days out, the next report is the most likely near-term test of the move.
CME price reaction
CME last traded at $251.99, up $14.61 (+6.15%) from the previous close of $237.38. The session traded on 0.4× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $218.58 and $251.99, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on CME Group Inc. (CME)
The consensus analyst price target on CME Group Inc. (CME) is $303.33, 20.4% above the recent $251.99. Over the past 90 days analysts logged 2 upgrades, 10 maintains, and 1 downgrade. Here is how the bullish and bearish cases on CME line up.
The bullish case
- Wall Street's consensus price target of $303.33 implies +20.4% upside from $251.99.
- The Street's most bullish target is $324.00 (+28.6%).
- 2 analyst upgrades in the past 90 days, most recently Keefe, Bruyette & Woods to Outperform (2026-06-18).
- Strong 6.2% price move on light volume.
- CME Group beat Q2 earnings expectations on July 22, posting EPS of $2.99 versus consensus of $2.91 and revenue of $1.71 billion, driven by the second-highest trading volume in company history (PRNewswire, Zacks).
The bearish case
- 1 analyst downgrade in the past 90 days, most recently Erste Group to Hold (2026-06-05).
- CME Group Inc. (CME) moved -3.15% from $245.11 to $237.38 on 2026-07-21.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 22, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CME
Frequently asked questions about CME
Why did CME Group Inc. (CME) stock move?
CME climbed 6.2% to $251.99. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did CME stock rise?
CME gained 6.15% ($14.61) versus the prior close of $237.38, last trading at $251.99 on 0.4× average volume.
When is CME Group Inc.'s next earnings date?
CME's next earnings report is estimated for 2026-10-28 — about 98 days away.
What is the analyst price target for CME?
The consensus analyst price target for CME is $303.33, about 20.4% above the current $251.99. Over the past 90 days, analysts recorded 2 upgrades, 10 maintains, and 1 downgrade.
How BestStocks tracks CME
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CME-specific materiality thresholds, triggering an evidence check. It draws on 7 tracked change events for CME, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.